WesBanco Bank’s Axsome Therapeutics AXSM Stock Holding History

WesBanco Bank’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.83M	Buy	10,800 +2,000	+23%	+$345K	0.05%	256
2025 Q4	$1.61M	Sell	8,800 -4,500	-34%	-$628K	0.04%	279
2025 Q3	$1.62M	Hold	13,300	–	–	0.04%	281
2025 Q2	$1.39M	Hold	13,300	–	–	0.04%	300
2025 Q1	$1.55M	Hold	13,300	–	–	0.05%	245
2024 Q4	$1.13M	Hold	13,300	–	–	0.04%	299
2024 Q3	$1.2M	Hold	13,300	–	–	0.04%	290
2024 Q2	$1.07M	Buy	13,300 +5,000	+60%	+$370K	0.04%	284
2024 Q1	$662K	Buy	+8,300	New	+$697K	0.03%	369

Other funds holding AXSM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WesBanco Bank's AXSM Position: Q1 2026 in Review

WesBanco Bank increased its Axsome Therapeutics (AXSM) stake by 23% in Q1 2026, buying an estimated $345K and bringing the position to 10,800 shares worth $1.83M. The position accounts for 0.05% of the portfolio, ranked #256.

WesBanco Bank first reported a position in AXSM in Q1 2024 and has held it in 9 quarters since. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

WesBanco Bank held 10,800 shares of Axsome Therapeutics worth $1.83M as of Q1 2026.
WesBanco Bank bought 2,000 Axsome Therapeutics shares in Q1 2026, an estimated $345K.
Axsome Therapeutics made up 0.05% of WesBanco Bank's portfolio in Q1 2026, its #256 holding.
WesBanco Bank first reported a position in Axsome Therapeutics in Q1 2024 and has held it in 9 quarters since.
409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on WesBanco Bank's 13F filing for Q1 2026, filed 21 Apr 2026.